CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

India’s BIOCON taps Tabuk Pharmaceutical for MENA expansion

By Munikoti Rochan

07:51, 7 December 2021

A blurry view of a random drug store with medicines stacked on shelves
Drug maker to ship medicines to Middle East and North Africa – Photo: Shutterstock

Shares of India’s Biocon gained on Tuesday after the drugmaker informed the bourses of a tie-up with Tabuk Pharmaceutical Manufacturing Company to sell medicines in Middle East and northern Africa (MENA).

The stock rose 1.4% to INR364.80 at about noon on the National Stock Exchange (NSE) after the company said it has inked an agreement with Tabuk to “commercialise select speciality products in the Middle East”.

Biocon will develop and manufacture the speciality generic medicines for Tabuk, which will market and promote them in Saudi Arabia and its neighbouring countries. The so-called out-licensing deal “paves the way for Biocon’s expansion into the MENA region, to include Saudi Arabia, the UAE, Kuwait, Qatar, Oman and Iraq, in addition to Jordan and Lebanon”, showed a 7 December stock market statement.

Tabuk, which employs over 2,400 people across four production sites, is a part of the Saudi-based Astra Industrial Group, whose business interests include polymers, chemicals and steel.

Major milestone for Biocon

“Our partnership with Tabuk Pharmaceuticals is another significant step as we continue to expand our global presence with our portfolio of high quality, vertically-integrated generic formulations, to address unmet medical needs,” said Biocon chief executive Siddharth Mittal. “We are extremely pleased to collaborate with Tabuk, whose deep expertise will help us build a solid foundation in key Middle East markets.”


6.49 Price
-1.530% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.04


243.74 Price
+0.430% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.22


475.08 Price
+2.100% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.14


15.56 Price
-4.230% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.16

“We are excited at Tabuk to partner with an innovation-led company like Biocon to commercialise difficult-to-make products that build on our strategy to expand our specialty business and reinforce our leading position in the region,” commented Tabuk Pharmaceutical’s vice president of strategy and business development Wisam Alkhatib.

“Our aspiration is to be the partner of choice to Biocon in the region and consider further collaboration with a rich pipeline of products.”

BIOCON has a market capitalisation of around INR431bn ($5.7bn) on the NSE, where its stock has dropped some 22% so far this year.


Read more: Qualcomm-backed CE Info Systems fixes IPO float price band

Rate this article

The difference between trading assets and CFDs
The main difference between CFD trading and trading assets, such as commodities and stocks, is that you don’t own the underlying asset when you trade on a CFD.
You can still benefit if the market moves in your favour, or make a loss if it moves against you. However, with traditional trading you enter a contract to exchange the legal ownership of the individual shares or the commodities for money, and you own this until you sell it again.
CFDs are leveraged products, which means that you only need to deposit a percentage of the full value of the CFD trade in order to open a position. But with traditional trading, you buy the assets for the full amount. In the UK, there is no stamp duty on CFD trading, but there is when you buy stocks, for example.
CFDs attract overnight costs to hold the trades (unless you use 1-1 leverage), which makes them more suited to short-term trading opportunities. Stocks and commodities are more normally bought and held for longer. You might also pay a broker commission or fees when buying and selling assets direct and you’d need somewhere to store them safely.
Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading